Advisory Committee on the Medical Uses of Isotopes: Meeting Notice

Issuing agencies

Abstract

The U.S. Nuclear Regulatory Commission (NRC) will convene a virtual meeting of the Advisory Committee on the Medical Uses of Isotopes (ACMUI) on October 26-27, 2026. Agenda items to be discussed during the public session include: a presentation on the outcome of the pilot on exploring using AI to search data in the Nuclear Materials Event Database (NMED), recommendations from ACMUI's subcommittee on radiopharmaceutical production and distribution safety, a presentation on radiological health at the U.S. Food and Drug Administration (FDA), and a presentation on recent medical events. The agenda is subject to change. The current agenda and any updates will be available on the ACMUI's Meetings and Related Documents web page at ACMUI Meetings and Related Documents: 2026 [verbar] Nuclear Regulatory Commission or by emailing Ms. Sarah Hoenig at the contact information below. Purpose: Discuss issues related to 10 CFR part 35 Medical Use of Byproduct Material.

Full Text

<html>
<head>
<title>Federal Register, Volume 91 Issue 195 (Friday, October 9, 2026)</title>
</head>
<body><pre>
[Federal Register Volume 91, Number 195 (Friday, October 9, 2026)]
[Notices]
[Pages 64700-64701]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2026-20733]


=======================================================================
-----------------------------------------------------------------------

NUCLEAR REGULATORY COMMISSION


Advisory Committee on the Medical Uses of Isotopes: Meeting 
Notice

AGENCY: U.S. Nuclear Regulatory Commission.

ACTION: Notice of meeting.

-----------------------------------------------------------------------

SUMMARY: The U.S. Nuclear Regulatory Commission (NRC) will convene a 
virtual meeting of the Advisory Committee on the Medical Uses of 
Isotopes (ACMUI) on October 26-27, 2026. Agenda items to be discussed 
during the public session include: a presentation on the outcome of the 
pilot on exploring using AI to search data in the Nuclear Materials 
Event Database (NMED), recommendations from ACMUI's subcommittee on 
radiopharmaceutical production and distribution safety, a presentation 
on radiological health at the U.S. Food and Drug Administration (FDA), 
and a presentation on recent medical events. The agenda is subject to 
change. The current agenda and any updates will be available on the 
ACMUI's Meetings and Related Documents web page at ACMUI Meetings and 
Related Documents: 2026 [verbar] Nuclear Regulatory Commission or by 
emailing Ms. Sarah Hoenig at the contact information below. Purpose: 
Discuss issues related to 10 CFR part 35 Medical Use of Byproduct 
Material.

[[Page 64701]]


DATES: Date and Time for Open Session: October 26, 2026, from 10:00 
a.m. to 2:45 p.m. EDT.
    Date and Time for Closed Session: October 27, 2026, from 11:00 a.m. 
to 12:30 p.m. EDT. This session will be closed to conduct the ACMUI's 
required annual training.

ADDRESSES: 

------------------------------------------------------------------------
                                       Webinar information (Microsoft
               Date                                Teams)
------------------------------------------------------------------------
October 26, 2026..................  Link: <a href="https://teams.microsoft.com/meet/213166283153366?p=5pGC3QyZeNAhXyq69K">https://teams.microsoft.com/meet/213166283153366?p=5pGC3QyZeNAhXyq69K</a> K.
                                    Meeting ID: 213 166 283 153 366.
                                    Passcode: 85E2QM7g.
                                    Call in number (audio only): +1 301-
                                     576-2978, United States, Silver
                                     Spring.
                                    Phone conference ID: 739 970 19#.
------------------------------------------------------------------------

    Public Participation: Any member of the public who wishes to 
participate in the meeting via Microsoft Teams or via phone should 
contact Ms. Sarah Hoenig using the information below.

FOR FURTHER INFORMATION CONTACT:  Ms. Sarah Hoenig, email: 
<a href="/cdn-cgi/l/email-protection#acdfcddecdc482c4c3c9c2c5cbecc2decf82cbc3da"><span class="__cf_email__" data-cfemail="b5c6d4c7d4dd9bdddad0dbdcd2f5dbc7d69bd2dac3">[email&#160;protected]</span></a> phone: 301-415-3284.

SUPPLEMENTARY INFORMATION:

Conduct of the Meeting

    The ACMUI Chair, Hossein Jadvar, MD, Ph.D., will preside over the 
meeting. Dr. Jadvar will conduct the meeting in a manner that will 
facilitate the orderly conduct of business. The following procedures 
apply to public participation in the meeting:
    1. Persons who wish to provide a written statement should submit an 
electronic copy to Ms. Sarah Hoenig using the contact information 
listed above. All submittals must be received by the close of business 
on October 19, 2026, and must only pertain to the topics on the agenda.
    2. Questions and comments from members of the public will be 
permitted during the meeting, at the discretion of the ACMUI Chair.
    3. The draft transcript and meeting summary will be available on 
ACMUI's website ACMUI Meetings and Related Documents: 2026 [verbar] 
Nuclear Regulatory Commission on or about November 27, 2026.
    4. Persons who require special services, such as those for the 
hearing impaired, should notify Ms. Sarah Hoenig of their planned 
participation.
    This meeting will be held in accordance with the Atomic Energy Act 
of 1954, as amended (primarily 42 U.S.C. 2201(a)); the Federal Advisory 
Committee Act (5 U.S.C. 1001 et seq.)); and the Commission's 
regulations in Title 10 of the Code of Federal Regulations, Part 7.
    Dated at Rockville, Maryland this 7th day of October 2026.

    For the U.S. Nuclear Regulatory Commission.
Russell E. Chazell,
Federal Advisory Committee Management Officer.
[FR Doc. 2026-20733 Filed 10-8-26; 8:45 am]
BILLING CODE 7590-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>